Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Higher versus lower nut consumption and changes in cognitive performance over two years in a population at risk of cognitive decline: a cohort study

  • Ni, Jiaqi
  • Cano Ibáñez, Naomi|||0000-0002-3640-5486
  • Martínez Diz, Silvia
  • Predimed-Plus Investigators
This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatologia de la Obesidad y Nutricio?n (CIBEROBN) and Instituto de Salud Carlos III (ISCIII) , through the Fondo de Investigacion para la Salud (FIS) , which is co-funded by the European Regional Development Fund (6 coordinated FIS projects leaded by JS-S and JoV, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158) ; the Especial Action Project entitled: Implementacion y evaluacion de una intervencion intensiva sobre la actividad fisica Cohorte PREDIMED-Plus grant and the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the European Research Council (Advanced Research Grant 2014-2019; agreement #340918) ; grants from the Consejeria de Salud de la Junta de Andalucia (PI0458/2013, PS0358/2016, PI0137/2018) ; the PROMETEO/2017/017 and PROMETEO/2021/021 grants from the Conselleria de Innovacio?n, Universidades, Ciencia y Sociedad digital de la Generalitat Valenciana; Grant PID2019-108858RB-I00 funded by AEI 10.13039/501100011033 and by "ERDF A way of making Europe"; the SEMERGEN grant; the AICO/2021/347 grants from the Generalitat Valenciana. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/H2020-SFS-2016-2) ; and the Horizon 2020 PRIME study (Prevention and Remediation of Insulin Multimorbidity in Europe; grant agreement #847879) . JN is supported by a predoctoral grant from Ministerio de Ciencia, Innovacion y Universidades (FPU 20/00385) . SKN is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR) . JS-S, the senior author of this paper, was partially supported by ICREA under the ICREA Academia program. None of the funding sources took part in the design,collection, analysis, interpretation of the data, writing the report, or in the decision to submit the manuscript for publication., Background: Tree nuts and peanuts (henceforth, nuts) are nutrient-dense foods rich in neuroprotective components; thus, their consumption could benefit cognitive health. However, evidence to date is limited and inconsistent regarding the potential benefits of nuts for cognitive function.Objective: To prospectively evaluate the association between nut consumption and 2-y changes in cognitive performance in older adults at cognitive decline risk.Methods: A total of 6,630 participants aged 55 to 75 y (mean age 65.0 & PLUSMN;4.9 y, 48.4% women) with overweight/obesity and metabolic syndrome completed a validated semi-quantitative food frequency questionnaire and a comprehensive battery of neuropsychological tests at baseline and a 2-y follow-up. Composite cognitive scores were used to assess global, general, attention, and executive function domains. Nut consumption was categorized as <1, >1 to <3, >3 to <7, and >7 servings/wk (1 serving=30 g). Multivariable-adjusted linear regression models were fitted to assess associations between baseline nut consumption and 2-y cognitive changes.Results: Nut consumption was positively associated with 2-y changes in general cognitive function (P-trend <0.001). Compared with participants consuming <1 serving/wk of nuts, those categorized as consuming >3 to <7 and >7 servings/wk showed more favorable changes in general cognitive performance (& beta; z-score [95% CI] = 0.06 [0.00,0.12] and 0.13 [0.06,0.20], respectively). No significant changes were observed in the multivariableadjusted models for other cognitive domains assessed.Conclusion: Frequent nut consumption was associated with a smaller decline in general cognitive performance over 2 y in older adults at risk of cognitive decline. Randomized clinical trials to verify our findings are warranted., Official Spanish Institutions, Instituto de Salud Carlos III (ISCIII) , Fondo de Investigacion para la Salud (FIS) - European Regional Development Fund PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158, La Caixa Foundation 2013ACUP00194, Junta de Andalucía PI0458/2013, PS0358/2016, PI0137/2018, PROMETEO/2017/017, Conselleria de Innovación, Universidades PID2019-108858RB-I00, AICO/2021/347, Center for Forestry Research & Experimentation (CIEF) EU-H2020: Eat2beNICE/H2020-SFS-2016-2, Horizon 2020 PRIME study 847879, Spanish Government FPU 20/00385, Ministerio de Ciencia, Innovación y Universidades FPU 20/00385, Canadian Institutes of Health Research (CIHR), ICREA under the ICREA Academia program
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention

  • Soldevila-Domenech, Natalia
  • Fagundo, Ana Beatriz
  • Cuenca Royo, Aida
  • Forcano Gamazo, Laura
  • Gomis-Gonzalez, Maria
  • Boronat, Anna
  • Pastor, Antoni
  • Castañer, Olga
  • Zomeño, M. Dolores
  • Goday, Alberto
  • Dierssen, Mara
  • Baghizadeh Hosseini, Khashayar
  • Ros Rahola, Emilio
  • Corella Piquer, Dolores
  • Martínez-González, Miguel Ángel
  • Salas Salvadó, Jordi
  • Fernández-Aranda, Fernando
  • Fitó Colomer, Montserrat
  • de la Torre, Rafael
Background The Mediterranean diet (MedDiet) has demonstrated efficacy in preventing age-related cognitive decline and modulating plasma concentrations of endocannabinoids (eCBs) and N-acylethanolamines (NAEs, or eCB-like compounds), which are lipid mediators involved in multiple neurological disorders and metabolic processes. Hypothesizing that eCBs and NAEs will be biomarkers of a MedDiet intervention and will be related to the cognitive response, we investigated this relationship according to sex and apolipoprotein E (APOE) genotype, which may affect eCBs and cognitive performance. Methods This was a prospective cohort study of 102 participants (53.9% women, 18.8% APOE-ɛ4 carriers, aged 65.6 ± 4.5 years) from the PREDIMED-Plus-Cognition substudy, who were recruited at the Hospital del Mar Research Institute (Barcelona). All of them presented metabolic syndrome plus overweight/obesity (inclusion criteria of the PREDIMED-Plus) and normal cognitive performance at baseline (inclusion criteria of this substudy). A comprehensive battery of neuropsychological tests was administered at baseline and after 1 and 3 years. Plasma concentrations of eCBs and NAEs, including 2-arachidonoylglycerol (2-AG), anandamide (AEA), oleoylethanolamide (OEA), palmitoylethanolamide (PEA), and N-docosahexaenoylethanolamine (DHEA), were also monitored. Baseline cognition, cognitive changes, and the association between eCBs/NAEs and cognition were evaluated according to gender (crude models), sex (adjusted models), and APOE genotype. Results At baseline, men had better executive function and global cognition than women (the effect size of gender differences was − 0.49, p = 0.015; and − 0.42, p = 0.036); however, these differences became nonsignificant in models of sex differences. After 3 years of MedDiet intervention, participants exhibited modest improvements in memory and global cognition. However, greater memory changes were observed in men than in women (Cohen’s d of 0.40 vs. 0.25; p = 0.017). In men and APOE-ε4 carriers, 2-AG concentrations were inversely associated with baseline cognition and cognitive changes, while in women, cognitive changes were positively linked to changes in DHEA and the DHEA/AEA ratio. In men, changes in the OEA/AEA and OEA/PEA ratios were positively associated with cognitive changes. Conclusions The MedDiet improved participants’ cognitive performance but the effect size was small and negatively influenced by female sex. Changes in 2-AG, DHEA, the OEA/AEA, the OEA/PEA and the DHEA/AEA ratios were associated with cognitive changes in a sex- and APOE-dependent fashion. These results support the modulation of the endocannabinoid system as a potential therapeutic approach to prevent cognitive decline in at-risk populations., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Intensive weight-loss lifestyle intervention using Mediterranean diet and COVID-19 risk in older adults: secondary analysis of PREDIMED-Plus Trial

  • Shyam, S.
  • García-Gavilán, Jesús
  • Paz Graniel, Indira
  • Gaforio, Jose J
  • Martínez-González, Miguel Ángel
  • Corella Piquer, Dolores
  • Martínez, José Alfredo
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch Riba, Ramon
  • Tinahones Madueño, Francisco J.
  • Lapetra, José
  • Serra Majem, Lluís
  • Bueno-Cavanillas, Aurora
  • Tur, Josep A.
  • Martín Sánchez, Vicente
  • Pintó Sala, Xavier
  • Matía Martín, Pilar
  • Vidal, Josep
  • Alcarria, M. del Mar
  • Daimiel, Lidia
  • Ros Rahola, Emilio
  • Fernández-Aranda, Fernando
  • Nishi, Stephanie K.
  • García Regata, Óscar
  • Pérez-Araluce, Rafael
  • Asensio, Eva Maria
  • Castañer, Olga
  • Garcia-Rios, Antonio
  • Oncina Canovas, Alejandro
  • Bouzas, Cristina
  • Zulet, M. Angeles
  • Rayó Gago, Elena
  • Casas, Rosa
  • Martin-Pelaez, S.
  • Tojal Sierra, Lucas
  • Bernal-López, M. Rosa
  • Carlos, Silvia
  • Sorlí, José V.
  • Goday, Alberto
  • Peña Orihuela, Patricia J
  • Pastor-Morel, A.
  • Eguaras, Sonia
  • Zomeño, M. Dolores
  • Delgado-Rodríguez, Miguel
  • Babio, Nancy
  • Fitó Colomer, Montserrat
  • Salas Salvadó, Jordi
Objectives We tested the effects of a weight-loss intervention encouraging energy-reduced MedDiet and physical activity (PA) in comparison to ad libitum MedDiet on COVID-19 incidence in older adults. Design Secondary analysis of PREDIMED-Plus, a prospective, ongoing, multicentre randomized controlled trial. Setting Community-dwelling, free-living participants in PREDIMED-Plus trial. Participants 6,874 Spanish older adults (55–75 years, 49% women) with overweight/obesity and metabolic syndrome. Intervention Participants were randomised to Intervention (IG) or Control (CG) Group. IG received intensive behavioural intervention for weight loss with an energy-reduced MedDiet intervention and PA promotion. CG was encouraged to consume ad libitum MedDiet without PA recommendations. Measurements COVID-19 was ascertained by an independent Event Committee until December 31, 2021. COX regression models compared the effect of PREDIMED-Plus interventions on COVID-19 risk. Results Overall, 653 COVID-19 incident cases were documented (IG:317; CG:336) over a median (IQR) follow-up of 5.8 (1.3) years (inclusive of 4.0 (1.2) years before community transmission of COVID-19) in both groups. A significantly lowered risk of COVID-19 incidence was not evident in IG, compared to CG (fully-adjusted HR (95% CI): 0.96 (0.81,1.12)). Conclusions There was no evidence to show that an intensive weight-loss intervention encouraging energy-reduced MedDiet and PA significantly lowered COVID-19 risk in older adults with overweight/ obesity and metabolic syndrome in comparison to ad libitum MedDiet. Recommendations to improve adherence to MedDiet provided with or without lifestyle modification suggestions for weight loss may have similar effects in protecting against COVID-19 risk in older adults with high cardiovascular risks., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention

  • Soldevila-Domenech, Natalia
  • Fagundo, Ana Beatriz
  • Cuenca Royo, Aida
  • Forcano Gamazo, Laura
  • Gomis-Gonzalez, Maria
  • Boronat, Anna
  • Pastor, Antoni
  • Castañer, Olga
  • Zomeño, M. Dolores
  • Goday, Alberto
  • Dierssen, Mara
  • Baghizadeh Hosseini, Khashayar
  • Ros Rahola, Emilio
  • Corella Piquer, Dolores
  • Martínez-González, Miguel Ángel
  • Salas Salvadó, Jordi
  • Fernández-Aranda, Fernando
  • Fitó Colomer, Montserrat
  • de la Torre, Rafael
Background The Mediterranean diet (MedDiet) has demonstrated efficacy in preventing age-related cognitive decline and modulating plasma concentrations of endocannabinoids (eCBs) and N-acylethanolamines (NAEs, or eCB-like compounds), which are lipid mediators involved in multiple neurological disorders and metabolic processes. Hypothesizing that eCBs and NAEs will be biomarkers of a MedDiet intervention and will be related to the cognitive response, we investigated this relationship according to sex and apolipoprotein E (APOE) genotype, which may affect eCBs and cognitive performance. Methods This was a prospective cohort study of 102 participants (53.9% women, 18.8% APOE-ɛ4 carriers, aged 65.6 ± 4.5 years) from the PREDIMED-Plus-Cognition substudy, who were recruited at the Hospital del Mar Research Institute (Barcelona). All of them presented metabolic syndrome plus overweight/obesity (inclusion criteria of the PREDIMED-Plus) and normal cognitive performance at baseline (inclusion criteria of this substudy). A comprehensive battery of neuropsychological tests was administered at baseline and after 1 and 3 years. Plasma concentrations of eCBs and NAEs, including 2-arachidonoylglycerol (2-AG), anandamide (AEA), oleoylethanolamide (OEA), palmitoylethanolamide (PEA), and N-docosahexaenoylethanolamine (DHEA), were also monitored. Baseline cognition, cognitive changes, and the association between eCBs/NAEs and cognition were evaluated according to gender (crude models), sex (adjusted models), and APOE genotype. Results At baseline, men had better executive function and global cognition than women (the effect size of gender differences was − 0.49, p = 0.015; and − 0.42, p = 0.036); however, these differences became nonsignificant in models of sex differences. After 3 years of MedDiet intervention, participants exhibited modest improvements in memory and global cognition. However, greater memory changes were observed in men than in women (Cohen’s d of 0.40 vs. 0.25; p = 0.017). In men and APOE-ε4 carriers, 2-AG concentrations were inversely associated with baseline cognition and cognitive changes, while in women, cognitive changes were positively linked to changes in DHEA and the DHEA/AEA ratio. In men, changes in the OEA/AEA and OEA/PEA ratios were positively associated with cognitive changes. Conclusions The MedDiet improved participants’ cognitive performance but the effect size was small and negatively influenced by female sex. Changes in 2-AG, DHEA, the OEA/AEA, the OEA/PEA and the DHEA/AEA ratios were associated with cognitive changes in a sex- and APOE-dependent fashion. These results support the modulation of the endocannabinoid system as a potential therapeutic approach to prevent cognitive decline in at-risk populations., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Intensive weight-loss lifestyle intervention using Mediterranean diet and COVID-19 risk in older adults: secondary analysis of PREDIMED-Plus Trial

  • Shyam, S.
  • García-Gavilán, Jesús
  • Paz Graniel, Indira
  • Gaforio, Jose J
  • Martínez-González, Miguel Ángel
  • Corella Piquer, Dolores
  • Martínez, José Alfredo
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch Riba, Ramon
  • Tinahones Madueño, Francisco J.
  • Lapetra, José
  • Serra Majem, Lluís
  • Bueno-Cavanillas, Aurora
  • Tur, Josep A.
  • Martín Sánchez, Vicente
  • Pintó Sala, Xavier
  • Matía Martín, Pilar
  • Vidal, Josep
  • Alcarria, M. del Mar
  • Daimiel, Lidia
  • Ros Rahola, Emilio
  • Fernández-Aranda, Fernando
  • Nishi, Stephanie K.
  • García Regata, Óscar
  • Pérez-Araluce, Rafael
  • Asensio, Eva Maria
  • Castañer, Olga
  • Garcia-Rios, Antonio
  • Oncina Canovas, Alejandro
  • Bouzas, Cristina
  • Zulet, M. Angeles
  • Rayó Gago, Elena
  • Casas, Rosa
  • Martin-Pelaez, S.
  • Tojal Sierra, Lucas
  • Bernal-López, M. Rosa
  • Carlos, Silvia
  • Sorlí, José V.
  • Goday, Alberto
  • Peña Orihuela, Patricia J
  • Pastor-Morel, A.
  • Eguaras, Sonia
  • Zomeño, M. Dolores
  • Delgado-Rodríguez, Miguel
  • Babio, Nancy
  • Fitó Colomer, Montserrat
  • Salas Salvadó, Jordi
Objectives We tested the effects of a weight-loss intervention encouraging energy-reduced MedDiet and physical activity (PA) in comparison to ad libitum MedDiet on COVID-19 incidence in older adults. Design Secondary analysis of PREDIMED-Plus, a prospective, ongoing, multicentre randomized controlled trial. Setting Community-dwelling, free-living participants in PREDIMED-Plus trial. Participants 6,874 Spanish older adults (55–75 years, 49% women) with overweight/obesity and metabolic syndrome. Intervention Participants were randomised to Intervention (IG) or Control (CG) Group. IG received intensive behavioural intervention for weight loss with an energy-reduced MedDiet intervention and PA promotion. CG was encouraged to consume ad libitum MedDiet without PA recommendations. Measurements COVID-19 was ascertained by an independent Event Committee until December 31, 2021. COX regression models compared the effect of PREDIMED-Plus interventions on COVID-19 risk. Results Overall, 653 COVID-19 incident cases were documented (IG:317; CG:336) over a median (IQR) follow-up of 5.8 (1.3) years (inclusive of 4.0 (1.2) years before community transmission of COVID-19) in both groups. A significantly lowered risk of COVID-19 incidence was not evident in IG, compared to CG (fully-adjusted HR (95% CI): 0.96 (0.81,1.12)). Conclusions There was no evidence to show that an intensive weight-loss intervention encouraging energy-reduced MedDiet and PA significantly lowered COVID-19 risk in older adults with overweight/ obesity and metabolic syndrome in comparison to ad libitum MedDiet. Recommendations to improve adherence to MedDiet provided with or without lifestyle modification suggestions for weight loss may have similar effects in protecting against COVID-19 risk in older adults with high cardiovascular risks., info:eu-repo/semantics/publishedVersion